163 related articles for article (PubMed ID: 26255620)
1. Lipid parameters in patients with acute coronary syndromes versus stable coronary artery disease.
Vonbank A; Saely CH; Rein P; Drexel H
Eur J Clin Invest; 2015 Oct; 45(10):1092-7. PubMed ID: 26255620
[TBL] [Abstract][Full Text] [Related]
2. Factors predicting cardiovascular events in statin-treated diabetic and non-diabetic patients with coronary atherosclerosis.
Drexel H; Aczel S; Marte T; Vonbank A; Saely CH
Atherosclerosis; 2010 Feb; 208(2):484-9. PubMed ID: 19748621
[TBL] [Abstract][Full Text] [Related]
3. Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial).
Ballantyne CM; Pitt B; Loscalzo J; Cain VA; Raichlen JS
Am J Cardiol; 2013 Feb; 111(4):506-9. PubMed ID: 23237107
[TBL] [Abstract][Full Text] [Related]
4. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
[TBL] [Abstract][Full Text] [Related]
5. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
6. Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus.
Sprandel MC; Hueb WA; Segre A; Ramires JA; Kalil-Filho R; Maranhão RC
Cardiovasc Diabetol; 2015 Aug; 14():107. PubMed ID: 26268997
[TBL] [Abstract][Full Text] [Related]
7. Low serum LDL cholesterol in patients with type 2 diabetes: an analysis on two different patient populations.
Saely CH; Eber B; Pfeiffer KP; Drexel H;
Int J Cardiol; 2010 Oct; 144(3):394-8. PubMed ID: 19477539
[TBL] [Abstract][Full Text] [Related]
8. Fasting triglycerides predict recurrent ischemic events in patients with acute coronary syndrome treated with statins.
Schwartz GG; Abt M; Bao W; DeMicco D; Kallend D; Miller M; Mundl H; Olsson AG
J Am Coll Cardiol; 2015 Jun; 65(21):2267-75. PubMed ID: 26022813
[TBL] [Abstract][Full Text] [Related]
9. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
Querton L; Buysschaert M; Hermans MP
J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
[TBL] [Abstract][Full Text] [Related]
11. Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: the COMPACT-CAD study.
Kurogi K; Sugiyama S; Sakamoto K; Tayama S; Nakamura S; Biwa T; Matsui K; Ogawa H;
J Cardiol; 2013 Aug; 62(2):87-94. PubMed ID: 23672789
[TBL] [Abstract][Full Text] [Related]
12. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
13. [Elevated HDL is the main negative risk factor for coronary artery disease in the elderly patient with calcific aortic valve disease].
Bordalo AD; Nobre AL; Dantas M; Cravino J
Rev Port Cardiol; 2012 Jun; 31(6):415-24. PubMed ID: 22609029
[TBL] [Abstract][Full Text] [Related]
14. Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.
Sampalis JS; Bissonnette S; Habib R; Boukas S;
Ann Pharmacother; 2007 Sep; 41(9):1345-51. PubMed ID: 17666579
[TBL] [Abstract][Full Text] [Related]
15. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
16. Effect of atorvastatin on serum omentin-1 in patients with coronary artery disease.
Chen Q; Shang X; Yuan M; Liang L; Zhong X
Coron Artery Dis; 2017 Jan; 28(1):44-51. PubMed ID: 27749321
[TBL] [Abstract][Full Text] [Related]
17. Plasmalogens of high-density lipoproteins (HDL) are associated with coronary artery disease and anti-apoptotic activity of HDL.
Sutter I; Velagapudi S; Othman A; Riwanto M; Manz J; Rohrer L; Rentsch K; Hornemann T; Landmesser U; von Eckardstein A
Atherosclerosis; 2015 Aug; 241(2):539-46. PubMed ID: 26093887
[TBL] [Abstract][Full Text] [Related]
18. Circulating PCSK9 levels in acute coronary syndrome: Results from the PC-SCA-9 prospective study.
Cariou B; Guérin P; Le May C; Letocart V; Arnaud L; Guyomarch B; Pichelin M; Probst V
Diabetes Metab; 2017 Dec; 43(6):529-535. PubMed ID: 28865748
[TBL] [Abstract][Full Text] [Related]
19. The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease.
Patel PJ; Khera AV; Jafri K; Wilensky RL; Rader DJ
J Am Coll Cardiol; 2011 Nov; 58(20):2068-75. PubMed ID: 22051328
[TBL] [Abstract][Full Text] [Related]
20. Association of plasma apolipoprotein AV with lipid profiles in patients with acute coronary syndrome.
Huang XS; Zhao SP; Zhang Q; Bai L; Hu M
Atherosclerosis; 2009 Jun; 204(2):e99-102. PubMed ID: 19150068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
